KPTI logo

Karyopharm Therapeutics (KPTI)

Profile

Full Name

Karyopharm Therapeutics Inc.

Ticker Symbol

KPTI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 6, 2013

Indexes

Not included

Website

http://www.karyopharm.com

Employees

279

Key Details

Price

$4.26(+1.19%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$145.24M(-0.55% YoY)

Annual EPS

-$13.95(+25.60% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.26
KPTI price is $4.26

30-Day Relative Volume

0.28
KPTI 30-day relative volume is 0.28

Price Performance

Price Most recent change

+1.19%
KPTI price was up +1.19% on Apr 15, 2025

Price YTD change

-57.99%
KPTI price is down -57.99% since January 1st

Price 1-year change

-75.41%
KPTI price is down -75.41% year-on-year

Price 3-year change

-96.36%
KPTI price is down -96.36% over the past 3 years

Price Range

Price All-time high

$735.08
KPTI price is currently -99.42% below its historical high of $735.08

Price 3-year low

$3.51
KPTI price is currently +21.37% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$35.85M
KPTI market capitalization is $35.85 million

Market cap 3-year change

-94.21%
KPTI market capitalization is down -94.21% over the past 3 years

Market cap All-time high

$1.85B
KPTI market capitalization is currently -98.06% below its historical high of $1.85 billion

Market cap sector rank

33.31%
KPTI market capitalization is higher than 33.31% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+8.39%
KPTI shares outstanding is up +8.39% year-on-year

Shares Outstanding 3-Year Change

+58.95%
KPTI shares outstanding is up +58.95% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
KPTI beta value is unknown

200-day SMA

$10.69
KPTI price is currently -60.16% below its 200-day simple moving average

50-day SMA

$6.75
KPTI price is currently -36.89% below its 50-day simple moving average

RSI

-
KPTI 14-day relative strength index value is unknown

Volume

0.28
KPTI 30-day relative volume is 0.28

ATR

-
KPTI average true range value is unknown

10-day Historical Volatility

-
KPTI 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$145.24M
KPTI annual revenue is $145.24 million

Revenue Analysts estimate

$149.62M
KPTI annual revenue is currently -2.93% lower than the consensus analysts' forecast

Revenue 1-year change

-0.55%
KPTI annual revenue is down -0.55% year-on-year

Revenue Sector rank

60.56%
KPTI annual revenue is higher than 60.56% of companies in Healthcare sector

EPS

EPS

-$13.95
KPTI annual earnings per share is -$13.95

EPS Analysts estimate

-$11.18
KPTI annual earnings per share is currently +24.83% higher than the consensus analysts' forecast

EPS 1-year change

+25.6%
KPTI annual earnings per share is up +25.6% year-on-year

EPS Sector rank

9.36%
KPTI annual earnings per share is higher than 9.36% of companies in Healthcare sector

Profit

Gross profit

$139.23M
KPTI annual gross profit is $139.23 million

Gross margin

95.86%
KPTI annual gross profit margin is 95.86%

Operating profit

-$119.44M
KPTI annual operating income is -$119.44 million

Operating margin

-82.24%
KPTI annual operating profit margin is -82.24%

Net income

-$76.42M
KPTI annual net profit is -$76.42 million

Net margin

-52.62%
KPTI annual net profit margin is -52.62%

Expenses

Total expenses

$264.68M
KPTI annual total expenses is $264.68 million

Operating expenses

$258.67M
KPTI annual total operating expenses is $258.67 million

Cost of goods sold

$6.01M
KPTI annual cost of goods sold is $6.01 million

Selling, general & administrative expenses

$115.44M
KPTI annual SGA is $115.44 million

Depreciation and amortization

$340.00K
KPTI annual depreciation & amortization is $340.00 thousand

Interest expense

$37.42M
KPTI annual interest expense is $37.42 million

Income tax

$57.00K
KPTI annual income tax is $57.00 thousand

EBIT & EBITDA

EBIT

-$38.94M
KPTI annual earnings before interest & taxes is -$38.94 million

EBITDA

-$38.60M
KPTI annual EBITDA is -$38.60 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$164.42M
KPTI annual total assets is $164.42 million

Non current assets

$7.93M
KPTI annual long term assets is $7.93 million

Current assets

$156.49M
KPTI annual total current assets is $156.49 million

Cash and cash equivalents

$62.48M
KPTI annual cash & cash equivalents is $62.48 million

Accounts receivable

$30.77M
KPTI annual accounts receivable is $30.77 million

Inventory

$4.74M
KPTI annual inventory is $4.74 million

Liabilities

Total liabilities

$350.44M
KPTI annual total liabilities is $350.44 million

Long term liabilities

$258.17M
KPTI annual total long term liabilities is $258.17 million

Current liabilities

$92.26M
KPTI annual total current liabilities is $92.26 million

Accounts payable

$5.11M
KPTI annual accounts payable is $5.11 million

Debt

Total debt

$194.52M
KPTI annual total debt is $194.52 million

Total debt 1-year change

+9.89%
KPTI annual total debt is up +9.89% year-on-year

Long term debt

$169.66M
KPTI annual long term debt is $169.66 million

Short term debt

$24.86M
KPTI annual short term debt is $24.86 million

Equity & Capital

Shareholders equity

-$186.02M
KPTI annual stockholders equity is -$186.02 million

Book value

-$186.02M
KPTI annual book value is -$186.02 million

Retained earnings

-$1.56B
KPTI annual retained earnings is -$1.56 billion

Working capital

$64.23M
KPTI annual working capital is $64.23 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$127.49M
KPTI annual cash flow from operations is -$127.49 million

Cash from operations 1-year change

-37.49%
KPTI annual cash flow from operations is down -37.49% year-on-year

Cash from investing

$95.47M
KPTI annual cash flow from investing activities is $95.47 million

Cash from investing 1-year change

+1102.43%
KPTI annual cash flow from investing activities is up +1102.43% year-on-year

Cash from financing

$41.65M
KPTI annual cash flow from financing activities is $41.65 million

Cash from financing 1-year change

+3605.16%
KPTI annual cash flow from financing activities is up +3605.16% year-on-year

CAPEX

CAPEX

$142.00K
KPTI annual capital expenditures is $142.00 thousand

CAPEX 1-year change

-
KPTI annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$127.63M
KPTI annual free cash flow is -$127.63 million

Free cash flow 1-year change

-37.64%
KPTI annual free cash flow is down -37.64% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

95.86%
KPTI annual gross profit margin is 95.86%

Operating margin

-82.24%
KPTI annual operating profit margin is -82.24%

Net margin

-52.62%
KPTI annual net profit margin is -52.62%

ROA & ROE

ROA

-37.75%
KPTI annual return on assets is -37.75%

ROE

41.08%
KPTI annual return on equity is 41.08%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
KPTI price to earnings ratio value is unknown

PE ratio Sector rank

-
KPTI price to earnings ratio is unknown

PB Ratio

PB ratio

-0.19
KPTI price to book ratio is -0.19

PB ratio Sector rank

11.85%
KPTI price to book ratio is higher than 11.85% of companies in Healthcare sector

PS Ratio

PS ratio

0.25
KPTI price to sales ratio is 0.25

PS ratio Sector rank

8.97%
KPTI price to sales ratio is higher than 8.97% of companies in Healthcare sector

Enterprise value

Enterprise value

$167.90M
KPTI enterprise value is $167.90 million

Enterprise value Sector rank

55.91%
KPTI enterprise value is higher than 55.91% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.35
KPTI EV/EBITDA is -4.35

EV/EBITDA Sector rank

20.28%
KPTI EV/EBITDA is higher than 20.28% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.70
KPTI annual current ratio is 1.70

Quick ratio

1.64
KPTI annual quick ratio is 1.64

Leverage

Debt to equity

-1.01
KPTI annual debt to equity ratio is -1.01

Interest coverage ratio

-1.04
KPTI annual interest coverage ratio is -1.04

Risk & Stability

Piotroski F-Score

3
KPTI piotroski f-score is 3

Altman Z-Score

-12.68
KPTI altman z-score is -12.68

Analyst ratings

Recent major analysts updates

Mar 3, 25 Baird
Outperform
Feb 26, 25 HC Wainwright & Co.
Buy
Feb 20, 25 RBC Capital
Outperform
Feb 20, 25 HC Wainwright & Co.
Buy
Feb 10, 25 RBC Capital
Outperform
Jan 15, 25 HC Wainwright & Co.
Buy
Nov 6, 24 Piper Sandler
Overweight
Nov 6, 24 HC Wainwright & Co.
Buy
Nov 1, 24 HC Wainwright & Co.
Buy
Aug 7, 24 RBC Capital
Outperform

Institutional Ownership

Similar stocks

MODD logo
Modular Medical (MODD)
SCYX logo
SCYNEXIS (SCYX)
FibroBiologics (FBLG)
XFOR logo
X4 Pharmaceuticals (XFOR)
SCLX logo
Scilex Holding (SCLX)
RMTI logo
Rockwell Medical (RMTI)
RVPH logo
Reviva Pharmaceuticals Holdings (RVPH)
ATRA logo
Atara Biotherapeutics (ATRA)
XLO logo
Xilio Therapeutics (XLO)
  • What is the ticker symbol for Karyopharm Therapeutics?
  • Does Karyopharm Therapeutics pay dividends?
  • What sector is Karyopharm Therapeutics in?
  • What industry is Karyopharm Therapeutics in?
  • What country is Karyopharm Therapeutics based in?
  • When did Karyopharm Therapeutics go public?
  • Is Karyopharm Therapeutics in the S&P 500?
  • Is Karyopharm Therapeutics in the NASDAQ 100?
  • Is Karyopharm Therapeutics in the Dow Jones?
  • When was Karyopharm Therapeutics's last earnings report?
  • When does Karyopharm Therapeutics report earnings?
  • Should I buy Karyopharm Therapeutics stock now?

What is the ticker symbol for Karyopharm Therapeutics?

The ticker symbol for Karyopharm Therapeutics is NASDAQ:KPTI

Does Karyopharm Therapeutics pay dividends?

No, Karyopharm Therapeutics does not pay dividends

What sector is Karyopharm Therapeutics in?

Karyopharm Therapeutics is in the Healthcare sector

What industry is Karyopharm Therapeutics in?

Karyopharm Therapeutics is in the Biotechnology industry

What country is Karyopharm Therapeutics based in?

Karyopharm Therapeutics is headquartered in United States

When did Karyopharm Therapeutics go public?

Karyopharm Therapeutics's initial public offering (IPO) was on November 6, 2013

Is Karyopharm Therapeutics in the S&P 500?

No, Karyopharm Therapeutics is not included in the S&P 500 index

Is Karyopharm Therapeutics in the NASDAQ 100?

No, Karyopharm Therapeutics is not included in the NASDAQ 100 index

Is Karyopharm Therapeutics in the Dow Jones?

No, Karyopharm Therapeutics is not included in the Dow Jones index

When was Karyopharm Therapeutics's last earnings report?

Karyopharm Therapeutics's most recent earnings report was on Feb 19, 2025

When does Karyopharm Therapeutics report earnings?

The next expected earnings date for Karyopharm Therapeutics is May 8, 2025

Should I buy Karyopharm Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page